Search Results - "Sjodahl, G."

Associations between bladder cancer molecular subtypes and metastatic sites by Sjödahl, G., Eriksson, P., Holmsten, K., Abrahamsson, J., Höglund, M., Bernardo, C., Ullén, A., Liedberg, F.

Get full text

Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes by Sjödahl, Gottfrid, Abrahamsson, Johan, Holmsten, Karin, Bernardo, Carina, Chebil, Gunilla, Eriksson, Pontus, Johansson, Iva, Kollberg, Petter, Lindh, Claes, Lövgren, Kristina, Marzouka, Nour-al-Dain, Olsson, Hans, Höglund, Mattias, Ullén, Anders, Liedberg, Fredrik

“…We observed different complete response rates and an independent association with survival in bladder cancer molecular subtypes for patients treated with…”
Get full text

Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer by Sjödahl, Gottfrid, Eriksson, Pontus, Holmsten, Karin, Abrahamsson, Johan, Höglund, Mattias, Bernardo, Carina, Ullén, Anders, Liedberg, Fredrik

“…Urothelial cancer of the urinary bladder frequently metastasizes to lymph‐nodes, lungs, liver and bone. A taxonomy for molecular classification exists, but it…”
Get full text

Reply to Joep J. de Jong and Ewan A. Gibb’s Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316–7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature? by Sjödahl, Gottfrid, Abrahamsson, Johan, Holmsten, Karin, Bernardo, Carina, Eriksson, Pontus, Kollberg, Petter, Marzouka, Nour-al-Dain, Höglund, Mattias, Ullén, Anders, Liedberg, Fredrik

Get full text

Po-326 genetic stability of multiple recurrences in bladder cancer patients by Marzouka, NAD, Eriksson, P, Lindgren, D, Liedberg, F, Bernardo, C, Sjödahl, G, Axelson, H, Höglund, M

“…IntroductionTo describe the origin and the genetic relationship between primary bladder tumours and their recurrences, different models were proposed, such as,…”
Get full text

Re: An Integrated Multi-Omics Analysis Identifies Prognostic Molecular Subtypes of Non-Muscle Invasive Bladder Cancer: Editorial Comment by Lindskrog, S. , V, Prip, F., Lamy, P., Taber, A., Groeneveld, C. S., Birkenkamp-Demtroder, K., Jensen, J. B., Strandgaard, T., Nordentoft, I, Christensen, E., Sokac, M., Birkbak, N. J., Maretty, L., Hermann, G. G., Petersen, A. C., Weyerer, V, Grimm, M-O, Horstmann, M., Sjodahl, G., Hoglund, M., Steiniche, T., Mogensen, K., de Reynies, A., Nawroth, R., Jordan, B., Lin, X., Dragicevic, D., Ward, D. G., Goel, A., Hurst, C. D., Raman, J. D., Warrick, J. , I, Segersten, Ulrika, Sikic, D., van Kessel, K. E. M., Maurer, T., Meeks, J. J., DeGraff, D. J., Bryan, R. T., Knowles, M. A., Simic, T., Hartmann, A., Zwarthoff, E. C., Malmstrom, P-O, Malats, N., Real, F. X., Dyrskjot, L.

Get full text

A1170 - Associations between bladder cancer molecular subtypes and metastatic sites by Sjödahl, G., Eriksson, P., Holmsten, K., Abrahamsson, J., Höglund, M., Bernardo, C., Ullén, A., Liedberg, F.

Get full text

Molecular subtype classification of advanced bladder cancer and matched lymph-node metastases by integrative immunohistochemistry, gene expression, and mutation analyses by Sjödahl, G, Eriksson, P, Lövgren, K, Liedberg, F, Höglund, M

Get full text

394 MRNA-based subtype classification of bladder cancer and patient outcome after radical cystectomy by Sjödahl, G, Kollberg, P, Liedberg, F, Höglund, M

Get full text

Recurring urothelial carcinomas are clonal but incompatible with a direct relationship by Marzouka, N, Lindgren, D, Eriksson, P, Sjödahl, G, Bernardo, C, Liedberg, F, Axelson, H, Höglund, M

“…To describe the genetic relationship between the primary and recurrent bladder tumors and to identify their origins, different models such as the field…”
Get full text

An evaluation of single-sample tumor subtype classification methods by Eriksson, P, Marzouka, NAD, Sjödahl, G, Bernardo, C, Liedberg, F, Höglund, M

“…Large efforts have been made to divide bladder cancer into prognostic or predictive subtypes by unsupervised or semi-supervised clustering of mRNA data. To…”
Get full text

Predictive and Prognostic Performance of IHC3 Immunohistochemistry-based Molecular Subtyping in Muscle-Invasive Bladder Cancer by Hardy, C, Jackson, CL, Chen, L, Sjödahl, G, Gooding, RJ, Berman, DM

“…Luminal/basal molecular subtyping in muscle-invasive bladder cancer (MIBC) has shown important relationships to prognosis and chemosensitivity, where tumours…”
Get full text

292 Circulating tumour cells in patients with advanced urothelial carcinoma of the bladder and correlation with tumour stage, lymph node metastases and FDG-PET-findings by Abrahamsson, J, Aaltonen, K, Engilbertsson, H, Liedberg, F, Patschan, O, Rydén, L, Sjödahl, G, Gudjonsson, S

Get full text

Pathologic downstaging after neoadjuvant cisplatin-based combination chemotherapy in immunohistochemistry-defined molecular subtypes of bladder cancer by Sjodahl, G., Abrahamsson, J., Holmsten, K., Eriksson, P., Lövgren, K., Lindh, C., Ullén, A., Liedberg, F.

Get full text

PT325 - Pathologic downstaging after neoadjuvant cisplatin-based combination chemotherapy in immunohistochemistry-defined molecular subtypes of bladder cancer by Sjodahl, G., Abrahamsson, J., Holmsten, K., Eriksson, P., Lövgren, K., Lindh, C., Ullén, A., Liedberg, F.

Get full text

STAG2 and PPARg as drivers of luminal-type bladder cancer by Lapi, E, Kalisz, M, Martínez de, Villareal J, Santos, C, Sjödahl, G, Dyrskjøt, L, Höglund, M, Losada, A, Real, FX

“…Several groups, including ours, have identified STAG2 as a new bladder tumor suppressor gene. STAG2 is part of cohesin, a complex involved in chromosome…”
Get full text

896 Defining molecular subtypes of urothelial carcinoma using tissue microarrays by Sjödahl, G, Lövgren, K, Fernö, M, Höglund, M

Get full text

Muscle invasive bladder cancer: A single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy by Seiler, R, Ashab, H.A.D, Erho, N, Van Rhijn, B.W, Winters, B, Douglas, J, Van Kessel, K, Fransen Van De Putte, E, Sommerlad, M, Wang, Q, Choeurng, V, Gibb, E, Palmer-Aronsten, B, Lam, L, Buerki, C, Davicioni, E, Sjödahl, G, Kardos, J, Hoadley, K, Lerner, S, McConkey, D, Choi, W, Kim, W, Kiss, B, Thalmann, G, Todenhöfer, T, Crabb, S, North, S, Zwarthoff, E, Boormans, J, Wright, J, Dall’Era, M, Van Der Heijden, M, Black, P

Get full text

217P Characterization of immune cells in the tumor microenvironment of advanced bladder cancer by Flaberg, E., Turkki, R., Paavolainen, L., Krantz, D., Välimäki, K., Schoonenberg, A., Moussaud, E., Holmsten, K., Costa Svedman, F., Kallioniemi, O., Abrahamsson, J., Liedberg, F., Sjödahl, G., Pellinen, T., Ullén, A., Östling, P.

Get full text

790 Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects outcome of patients with muscle-invasive tumors by Sjödahl, G, Lövgren, K, Lauss, M, Chebil, G, Patschan, O, Gudjonsson, S, Månsson, W, Fernö, M, Leandersson, K, Lindgren, D, Liedberg, F, Höglund, M

Get full text